Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 703691, 6 pages
http://dx.doi.org/10.1155/2014/703691
Research Article

Oxytocin Improves Follicular Reserve in a Cisplatin-Induced Gonadotoxicity Model in Rats

1Department of Physiology, Ege University School of Medicine, 35100 Izmir, Turkey
2Department of Obstetrics and Gynecology, Ege University School of Medicine, 35100 Izmir, Turkey
3Department of Histology and Embryology, Ege University School of Medicine, 35100 Izmir, Turkey
4Division of Medical Oncology, Tepecik Educational and Training Hospital, 35100 Izmir, Turkey

Received 23 February 2014; Revised 11 April 2014; Accepted 23 April 2014; Published 15 May 2014

Academic Editor: Christophe Duranton

Copyright © 2014 Oytun Erbaş et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Lee, L. R. Schover, A. H. Partridge et al., “American Society of Clinical Oncology recommendations on fertility preservation in cancer patients,” Journal of Clinical Oncology, vol. 24, no. 18, pp. 2917–2931, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Jeruss and T. K. Woodruff, “Preservation of fertility in patients with cancer,” New England Journal of Medicine, vol. 360, no. 9, pp. 858–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Boulikas and M. Vougiouka, “Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review),” Oncology reports, vol. 11, no. 3, pp. 559–595, 2004. View at Google Scholar · View at Scopus
  4. M. S. Yucebilgin, M. C. Terek, A. Ozsaran et al., “Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 44, no. 1, pp. 6–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Yeh, B. Kim, Y. J. Liang, and J. Peresie, “Müllerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage,” Biochemical and Biophysical Research Communications, vol. 348, no. 2, pp. 337–344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. G. Deavall, E. A. Martin, J. M. Horner, and R. Roberts, “Drug-induced oxidative stress and toxicity,” Journal of Toxicology, vol. 2012, Article ID 645460, 13 pages, 2012. View at Publisher · View at Google Scholar
  7. L. A. Rashed, R. M. Hashem, and H. M. Soliman, “Oxytocin inhibits NADPH oxidase and P38 MAPK in cisplatin-induced nephrotoxicity,” Biomedicine and Pharmacotherapy, vol. 65, no. 7, pp. 474–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Gimpl and F. Fahrenholz, “The oxytocin receptor system: structure, function, and regulation,” Physiological Reviews, vol. 81, no. 2, pp. 629–683, 2001. View at Google Scholar · View at Scopus
  9. J. Gutskowska and M. Jankowski, “Oxytocin: old hormone, new drug,” Pharmaceuticals, vol. 2, no. 3, pp. 168–183, 2009. View at Publisher · View at Google Scholar
  10. S. Ö. Işeri, G. Şener, B. Saǧlam, N. Gedik, F. Ercan, and B. Ç. Yeǧen, “Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism,” Peptides, vol. 26, no. 3, pp. 483–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. M. Alizadeh, M. Faghihi, V. Khori et al., “Oxytocin protects cardiomyocytes from apoptosis induced by ischemia-reperfusion in rat heart: role of mitochondrial ATP-dependent potassium channel and permeability transition pore,” Peptides, vol. 36, no. 1, pp. 71–77, 2012. View at Publisher · View at Google Scholar
  12. O. Erbas, F. Oltulu, and D. Taskiran, “Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment,” Peptides, vol. 38, no. 2, pp. 312–317, 2012. View at Publisher · View at Google Scholar
  13. O. Erbas, A. M. Ergenoglu, A. Akdemir, O. A. Yeniel, and D. Taskiran, “Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentallyinduced sepsis,” The Journal of Surgical Research, vol. 183, no. 1, pp. 313–320, 2012. View at Google Scholar
  14. O. Erbas, M. Yilmaz, H. A. Korkmaz, S. Bora, V. Evren, and G. Peker, “Oxytocin inhibits pentylentetrazol-induced seizures in the rat,” Peptides, vol. 40, pp. 141–144, 2013. View at Publisher · View at Google Scholar
  15. M. G. Farina, S. Billi, G. Leguizamón et al., “Secretory and cytosolic phospholipase A2 activities and expression are regulated by oxytocin and estradiol during labor,” Reproduction, vol. 134, no. 2, pp. 355–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Faghihi, A. M. Alizadeh, V. Khori, M. Latifpour, and S. Khodayari, “The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart,” Peptides, vol. 37, no. 2, pp. 314–319, 2012. View at Publisher · View at Google Scholar
  17. K. Oktay, R. S. Schenken, and J. F. Nelson, “Proliferating cell nuclear antigen marks the initiation of follicular growth in the rat,” Biology of Reproduction, vol. 53, no. 2, pp. 295–301, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Akdemir, O. Erbas, F. Gode et al., “Protective effect of oxytocin on ovarian ischemia-reperfusion injury in rats,” Peptides, vol. 55, pp. 126–130, 2014. View at Publisher · View at Google Scholar
  19. G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959. View at Google Scholar · View at Scopus
  20. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Google Scholar · View at Scopus
  21. G. I. Perez, D. V. Maravei, A. M. Trbovich, J. A. Cidlowski, J. L. Tilly, and J. Hughes F.M., “Identification of potassium-dependent and -independent components of the apoptotic machinery in mouse ovarian germ cells and granulosa cells,” Biology of Reproduction, vol. 63, no. 5, pp. 1358–1369, 2000. View at Google Scholar · View at Scopus
  22. D. Meirow, “Reproduction post-chemotherapy in young cancer patients,” Molecular and Cellular Endocrinology, vol. 169, no. 1-2, pp. 123–131, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Fanchin, L. M. Schonäuer, C. Righini, J. Guibourdenche, R. Frydman, and J. Taieb, “Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3,” Human Reproduction, vol. 18, no. 2, pp. 323–327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Muttukrishna, H. McGarrigle, R. Wakim, I. Khadum, D. M. Ranieri, and P. Serhal, “Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?” International Journal of Obstetrics and Gynaecology, vol. 112, no. 10, pp. 1384–1390, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. M. Lee and P. K. Donahoe, “Mullerian inhibiting substance: a gonadal hormone with multiple functions,” Endocrine Reviews, vol. 14, no. 2, pp. 152–164, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. G. Gruijters, J. A. Visser, A. L. L. Durlinger, and A. P. N. Themmen, “Anti-Müllerian hormone and its role in ovarian function,” Molecular and Cellular Endocrinology, vol. 211, no. 1-2, pp. 85–90, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Jayaprakasan, B. Campbell, J. Hopkisson, I. Johnson, and N. Raine-Fenning, “A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation,” Fertility and Sterility, vol. 93, no. 3, pp. 855–864, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Ozcelik, C. Turkyilmaz, M. T. Ozgun et al., “Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist,” Fertility and Sterility, vol. 93, no. 5, pp. 1609–1614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. E. Senturk, K. Erkanli, U. Aydin et al., “The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder,” Peptides, vol. 40, pp. 82–88, 2013. View at Publisher · View at Google Scholar
  30. K. D. Jacob, N. Noren Hooten, A. R. Trzeciak, and M. K. Evans, “Markers of oxidant stress that are clinically relevant in aging and age-related disease,” Mechanisms of Ageing and Development, vol. 134, no. 3-4, pp. 139–157, 2013. View at Publisher · View at Google Scholar
  31. A. Strunecká, S. Hynie, and V. Klenerová, “Role of oxytocin/oxytocin receptor system in regulation of cell growth and neoplastic processes,” Folia Biologica, vol. 55, no. 5, pp. 159–165, 2009. View at Google Scholar · View at Scopus
  32. D. Devost, P. Wrzal, and H. H. Zingg, “Oxytocin receptor signalling,” Progress in Brain Research, vol. 170, pp. 167–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Kobayashi, S. Yasuda, N. Bao et al., “Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis,” Journal of Cardiovascular Pharmacology, vol. 54, no. 6, pp. 510–519, 2009. View at Publisher · View at Google Scholar · View at Scopus